Who is sponsoring NCT04032379?

NCT04032379 is sponsored by Danish Headache Center.

What drugs are being tested in NCT04032379?

Interventions in NCT04032379: Standard treatment.

What condition does NCT04032379 study?

NCT04032379 studies Benign Intracranial Hypertension.

Is NCT04032379 still recruiting?

NCT04032379 is currently recruiting now. Last updated 7 March 2023.

Last reviewed 2023-03-07 · How we verify

NCT04032379

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diagnostic and Prognostic Biomarkers of Idiopathic Intracranial Hypertension

Recruiting now Last updated 7 March 2023

What this trial tests

trial testing Standard treatment in Benign Intracranial Hypertension in 300 participants. Currently enrolling.

Timeline

14 February 2018

Primary endpoint
31 May 2027

31 May 2027

Quick facts

Lead sponsor	Danish Headache Center
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	300
Start date	14 February 2018
Primary completion	31 May 2027
Estimated completion	31 May 2027
Sites	2 locations across Denmark

Drugs / interventions tested

Standard treatment

Conditions studied

Benign Intracranial Hypertension — all drugs for Benign Intracranial Hypertension →

Sponsor

Danish Headache Center — full company profile →

Who can join

18 and older, any sex, with Benign Intracranial Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Idiopathic intracranial hypertension (IIH) is a condition of unknown etiology, primarily affecting overweight females of childbearing age. Typically, patients experience headache and visual symptoms due to increased intracranial pressure (ICP) and papilledema. The diagnosis is difficult, and outcomes vary from no sequelae to blindness or chronic headaches. No clear prognostic indicators exist. Treatment consists of medication, weight loss, and possibly surgical intervention.There is an unmet need of defining biomarkers with prognostic or diagnostic value and defining predictors of a poor outcome. This project is a prospective, population-based cohort study including clinical data and a biobank (blood samples and cerebrospinal fluid). The investigator's primary aim is to identify biomarkers of diagnostic or prognostic value and to create a clinical IIH database. The clinical database will answer questions about patient characteristics at baseline and during follow-up, identify predictors of outcome, and help create a standardized programme for follow-up and

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Are the ICHD-3 criteria for headache attributed to idiopathic intracranial hypertension valid? Headache phenotyping and field-testing in newly diagnosed idiopathic intracranial hypertension.
Hansen NS, Korsbæk JJ, Yri HM, Jensen RH, et al · · 2024 · cited 7× · PMID 38663903 · DOI 10.1177/03331024241248210

Verify or expand the search:

Other trials of Standard treatment

Trials testing the same drug.

NCT07505667 — Yiyuancong for the Treatment of Sudden Sensorineural Hearing Loss · NA · recruiting
NCT07222852 — Cardiovascular Protection After Preeclampsia With Enalapril · Phase 3 · not yet recruiting
NCT07056764 — Development of Lung Vibration Equipment · NA · completed
NCT06440239 — A Study to Evaluate the Safety, Tolerability and Efficacy in Patients With Burn(s) · Phase 1, PHASE2 · not yet recruiting
NCT06612593 — Cilostazol in Parkinson's Disease · Phase 2 · not yet recruiting

Other Danish Headache Center trials

Trials by the same sponsor.

NCT07451769 — Selective Activation of the Adrenomedullin Receptors in Migraine · NA · not yet recruiting
NCT07342296 — Induction of Migraine Attacks With Aura Using Pituitary Adenylate Cyclase Activating Polypeptide-38 · NA · not yet recruiting
NCT07059546 — Hypersensitivity to Adrenomedullin in Post-Traumatic Headache · NA · recruiting
NCT07021859 — Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide · NA · recruiting
NCT06959004 — Substance P-Induced Migraine Attacks Without Aura · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04032379 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Danish Headache Center
Last refreshed: 7 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04032379.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing